Johanna Faris
General Counsel at SENZIME AB
Net worth: 754 $ as of 29/04/2024
Profile
Johanna Faris is currently the Director of Quality Assurance & Regulatory Affairs at Senzime AB since 2018.
Prior to this, she worked as the Director of Regulatory & Quality Assurance at Biovica International AB from 2016 to 2018.
She also worked as a Manager of Quality Assurance & Regulatory at Fiomi Diagnostics AB.
Ms. Faris completed her undergraduate degree at the University of Uppsala.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
SENZIME AB
0.00% | 29/12/2022 | 1,183 ( 0.00% ) | 754 $ | 29/04/2024 |
Johanna Faris active positions
Companies | Position | Start |
---|---|---|
SENZIME AB | General Counsel | 31/12/2017 |
Former positions of Johanna Faris
Companies | Position | End |
---|---|---|
BIOVICA INTERNATIONAL AB | General Counsel | 31/07/2018 |
Fiomi Diagnostics AB
Fiomi Diagnostics AB Medical SpecialtiesHealth Technology Part of MiCo IVD Holdings, LLC, Fiomi Diagnostics AB is a Swedish company that develops, manufactures, and markets diagnostic test kits. The private company is based in Uppsala, Sweden. Fiomi Diagnostics was acquired by Trinity Biotech Plc on March 01, 2012 for $13.12 million. | General Counsel | - |
Training of Johanna Faris
University of Uppsala | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
BIOVICA INTERNATIONAL AB | Health Technology |
SENZIME AB | Health Technology |
Private companies | 1 |
---|---|
Fiomi Diagnostics AB
Fiomi Diagnostics AB Medical SpecialtiesHealth Technology Part of MiCo IVD Holdings, LLC, Fiomi Diagnostics AB is a Swedish company that develops, manufactures, and markets diagnostic test kits. The private company is based in Uppsala, Sweden. Fiomi Diagnostics was acquired by Trinity Biotech Plc on March 01, 2012 for $13.12 million. | Health Technology |
- Stock Market
- Insiders
- Johanna Faris